Results 121 to 130 of about 448 (162)

A Modern Approach to Clinical Outcome Assessment in Allergy Management: Advantages of Allergen Exposure Chambers. [PDF]

J Clin Med
Zemelka-Wiacek M.
europepmc   +1 more source

Association between Antihistamine Use and Clinical Outcomes in Patients on Maintenance Hemodialysis. [PDF]

Kidney Dis (Basel)
Jeon J, Lim YJ, Kim BY, Choi JY, Do JY, Lee JE, Kang SH.   +6 more
europepmc   +1 more source

The dual immune landscape of homologous recombination-deficient tumors: mechanisms and therapeutic implications. [PDF]

Cancer Metastasis Rev
Yang Y, Yin Y, Rong S, Qian Y, Li D, Zhang Y, Wang X.   +6 more
europepmc   +1 more source

Copper-Catalyzed Selective Amino-alkoxycarbonylation of Unactivated Alkenes with CO. [PDF]

J Am Chem Soc
Yan SS, Jackstell R, Beller M.
europepmc   +1 more source

Successful treatment of vasospastic angina refractory to various therapies using stenting: A case report. [PDF]

J Cardiol Cases
Ono M, Okabe T, Isomura N, Ochiai M.
europepmc   +1 more source

Non-clinical pharmacology, pharmacokinetics, and safety findings for the antihistamine bepotastine besilate

Current Medical Research and Opinion, 2010
The purpose of this review is to examine published non-clinical literature on the antihistamine bepotastine besilate, including pharmacokinetic and pharmacologic properties.Standard literature searches using diverse databases were used to find articles on bepotastine besilate published between 1997 and 2009.
Sharon M Klier
exaly   +4 more sources

Characterization of Photodegradation Products of Bepotastine Besilate and In Silico Evaluation of Their Physicochemical, Absorption, Distribution, Metabolism, Excretion and Toxicity Properties

Journal of Pharmaceutical Sciences, 2020
Bepotastine (BPT) is a H1-receptor antagonist. It is used as a besilate salt in ophthalmic solution for allergic conjunctivitis and orally for the treatment of allergic rhinitis and urticaria/pruritus.
Asit K Chakraborti, Prasad V. Bharatam, Saranjit Singh   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Bepotastine besilate for the treatment of perennial allergic rhinitis

Expert Opinion on Pharmacotherapy, 2018
Bepotastine besilate (BB) is a second-generation H1-antihistamine that, as an ophthalmic solution, is approved in the United States by the Food and Drug Administration (FDA) for the treatment of allergic conjunctivitis. In other countries, the oral presentation of BB is widely used for the improvement of symptoms of allergic rhinitis (AR) as well as ...
Alexei Gonzalez-Estrada, Ismael Carrillo-Martin, Vés Dimov   +2 more
exaly   +3 more sources